# Final two-reviewer consensus

Date recorded: 2026-10-05. Authority: the user's explicit adjudication and the assistant's unqualified acceptance in the current conversation. This is a record of that agreement, not a new independent review or a journal decision.

**Verdict: MINOR REVISION FOR STATED SCOPE.**

Stated scope: an internal, unweighted, cross-sectional methodological benchmark of seven fixed classifiers for self-reported diagnosed diabetes status in BRFSS 2025.

| Issue | Final agreement |
|---|---|
| A01 | MINOR: incomplete evidence of prospective joint prespecification / test exposure. Current evidence does not demonstrate adaptive model-selection contamination. |
| A02 | MINOR: pre-split covariate-coverage inspection. The prior train-only counterfactual did not demonstrate practical feature-set impact. |
| External validation | An applicability limitation, not an automatic major defect for the stated scope. |
| Calibration | Reconstruction accepted; joint intercept/slope distinguished from calibration-in-the-large; diagnostics only. |
| Paired bootstrap | The 5,000-replicate reconstruction is accepted. |
| LR versus XGBoost AP | Exploratory and metric-specific; does not establish overall superiority. |
| 160 passing tests | Engineering/reproducibility support only; not scientific validity by themselves. |
| Historical 69 to 82 score | Not a defensible readiness score: finding-level deduction attribution was not recorded. No replacement numerical score is assigned. |
| Open scientific-validity defects | No unresolved FATAL or MAJOR scientific-validity defects demonstrated by current evidence. This is not proof that all possible biases are absent. |
| Submission readiness | Not submission-ready: manuscript/reporting/artifact/author-required items remain. |

Frozen results remain usable as exploratory/descriptive estimates for this internal sample, with their stated conditional uncertainty. Neither prospective incidence prediction, national population performance, external transportability, fairness, causal effects, clinical utility, overall algorithm superiority nor equivalence is established.

## Counterfactual interpretation retained from adjudication

The earlier read-only reassessment reconstructed the frozen split (274,031 training; 68,508 test) and checked test row order and labels against frozen predictions. All 31 non-leakage candidates were below the referenced 20% missingness threshold in both full-data and training-only inspection. The threshold alone admits 31 candidates, not 20. The same final 20 follow only when the recorded qualitative domain/redundancy/leakage choices are held constant. There is no complete executable selector establishing an unconditional automatic selection of exactly 20. This paragraph records the prior reassessment; no counterfactual was rerun during this documentation task.

## History and current purpose

The earlier `ASTRA_FINAL_AUDIT_VI.md`, issue ledger and verification records remain historical evidence. Their MAJOR REVISION verdict and numerical score are superseded for current interpretation by this consensus; historical files have not been rewritten.

The user's subsequent instruction prioritizes understanding the study and reporting to a supervisor, not journal submission. Current reading order: `BAO_CAO_GVHD_VI.md`, then `GIAI_THICH_FULL_STUDY_VI.md`. Journal formatting, author declarations and a durable public artifact release remain later tasks. No model, predictor, cohort, split, threshold or frozen prediction changes are authorized by this documentation update.
